BioDelivery Sciences International Inc. NASDAQ:BDSI BioDelivery Sciences International, Inc. is a commercial-stage specialty pharmaceutical company dedicated to patients living with chronic conditions. BDSI has built a portfolio of products that includes utilizing its novel and proprietary BioErodible MucoAdhesive (BEMA®) technology to develop and commercialize, either on its own or in partnership with third parties, new applications of proven therapies aimed at addressing important unmet medical needs. BDSI's marketed products address serious and debilitating conditions, including chronic pain and opioid-induced constipation.

Location: 4131 Parklake Ave Ste 225, North Carolina, 27612-2390, US | Website: www.bdsi.com | Industry: Pharmaceutical Preparation Manufacturing | Sector: Manufacturing